A study by the European
Animal Research Association (EARA), of websites of biomedical research bodies
in Germany, assessing how they discuss research using animals, has found that the
sector is still some way from an acceptable level of openness and transparency
in animal research.
a total of 151 institutional websites in Germany during 2018, both public and
private bodies, such as universities and pharmaceutical companies, and a rating
system was developed to analyse the data. The main findings were that:
Just a third (34%) of the institutions
conducting animal research carry a recognisable statement on their websites
explaining the use of animals in research/animal welfare.
Just over half the websites assessed (55%) meet
the criterion for providing ‘more information’, for instance by including the
kind of animals used.
Well under a third (28%) of the websites can
be considered to have prominent mentions of animal research – such as
recognisable statements within three clicks of the homepage.
The Federation of European Neuroscience Societies (FENS) has responded to the recent European Parliament’s Intergroup on the Welfare and Conservation of Animals statement on the use of animals in neuroscience, which claimed that, ‘Animal testing is inherently uncertain and is a misleading indicator for human trials’.
In its own response statement FENS said: ‘The value of animal-based research for wide-reaching scientific and medical advances, including in neuroscience, cannot be overstated.’
The statement, also backed by EARA, EFPIA, GIRCOR, RSB, TVV and Wellcome, continued: ‘While there is an element of uncertainty in drug-related R&D, the use of animals in neuroscience research has undoubtedly contributed to our ever-improving understanding of the human brain and important advances in the treatment of neurological diseases.’
EARA Brexit Taskforce Briefing on the potential implications for animal science in the UK and EU stemming from Brexit
EARA has brought together a group of organisations under a Brexit Taskforce. The Taskforce is comprised of the following organisations – EARA, ABPI, AnimalHealth Europe, Charles River Laboratories, Covance, Ellegaard Göttingen Minipigs, Envigo, GSK, Marshall BIoResources, National Office of Animal Health, Understanding Animal Research and the Wellcome Sanger Institute.
The Task Force has produced this briefing which addresses both the complexities and possible opportunities for animal science in Europe stemming from Exit. Read the briefing here
The aim of this initiative is to allow the wider biomedical sector the opportunity to raise concerns with both the 27 (through EU engagement) and UK authorities on outstanding and unresolved issues over Brexit and animal science. If you have any questions about the briefing or believe that your organisation would benefit from joining the Task Force please contact us at email@example.com
The Italian legislative decree No. 26 of 4th March 2014 transposes to the Italian law the European Directive No. 63 of 22nd September 2010. The legislative decree 26/2014 introduced unprecedented provisions regarding to 1) the use of animals for xenotransplantation and substances of abuse research (Art. 5, part 2. letter d. and e) 2) the use of animals for training and education in universities (Art. 5, part 2. letter f), 3) breeding cats, dogs and non-human primates (Art. 10, part 5). Continue reading →